Creo Medical Group PLC (AIM:CREO)

Creo Medical Group Statistics

Total Valuation

AIM:CREO has a market cap or net worth of GBP 63.68 million. The enterprise value is 55.38 million.

Market Cap	63.68M
Enterprise Value	55.38M

Important Dates

The last earnings date was Wednesday, May 27, 2026.

Earnings Date	May 27, 2026
Ex-Dividend Date	n/a

Share Statistics

AIM:CREO has 439.14 million shares outstanding. The number of shares has increased by 43.25% in one year.

Current Share Class	439.14M
Shares Outstanding	439.14M
Shares Change (YoY)	+43.25%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	79.13%
Float	400.57M

Valuation Ratios

The trailing PE ratio is 12.01.

PE Ratio	12.01
Forward PE	n/a
PS Ratio	10.61
PB Ratio	1.27
P/TBV Ratio	1.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	10.45
EV / Sales	9.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.08.

Current Ratio	3.22
Quick Ratio	2.64
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-65.00

Financial Efficiency

Return on equity (ROE) is -37.88% and return on invested capital (ROIC) is -46.76%.

Return on Equity (ROE)	-37.88%
Return on Assets (ROA)	-19.64%
Return on Invested Capital (ROIC)	-46.76%
Return on Capital Employed (ROCE)	-37.64%
Weighted Average Cost of Capital (WACC)	9.02%
Revenue Per Employee	46,512
Profits Per Employee	41,085
Employee Count	129
Asset Turnover	0.10
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.00% in the last 52 weeks. The beta is 0.90, so AIM:CREO's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	+4.00%
50-Day Moving Average	12.27
200-Day Moving Average	12.32
Relative Strength Index (RSI)	68.91
Average Volume (20 Days)	755,228

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:CREO had revenue of GBP 6.00 million and earned 5.30 million in profits. Earnings per share was 0.01.

Revenue	6.00M
Gross Profit	2.40M
Operating Income	-19.50M
Pretax Income	-17.50M
Net Income	5.30M
EBITDA	-18.50M
EBIT	-19.50M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 12.40 million in cash and 4.10 million in debt, with a net cash position of 8.30 million or 0.02 per share.

Cash & Cash Equivalents	12.40M
Total Debt	4.10M
Net Cash	8.30M
Net Cash Per Share	0.02
Equity (Book Value)	50.00M
Book Value Per Share	0.09
Working Capital	16.20M

Cash Flow

Operating Cash Flow	-19.10M
Capital Expenditures	n/a
Depreciation & Amortization	1.00M
Net Borrowing	-600,000
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 40.00%, with operating and profit margins of -325.00% and 88.33%.

Gross Margin	40.00%
Operating Margin	-325.00%
Pretax Margin	-291.67%
Profit Margin	88.33%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM:CREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.25%
Shareholder Yield	-43.25%
Earnings Yield	8.32%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3